ANTIPODES PARTNERS Ltd: ALNY position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on ALNY, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 163,533 ALNY shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 163,533 sharesChange vs previous 13F +18,223 shares
0.9% of the 13F portfolio, value $49,228,339.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 145,310 sharesChange vs previous 13F +97,424 shares
0.93% of the 13F portfolio, value $48,078,720.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 47,886 sharesChange vs previous 13F +15,930 shares
0.4% of the 13F portfolio, value $19,043,296.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 31,956 sharesChange vs previous 13F -90,848 shares
0.33% of the 13F portfolio, value $14,573,035.
13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 122,804 sharesChange vs previous 13F -36,750 shares
1.24% of the 13F portfolio, value $40,048,212.
13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 159,554 sharesChange vs previous 13F +25,795 shares
1.35% of the 13F portfolio, value $43,086,228.
13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 133,759 sharesChange vs previous 13F -5,616 shares
1.09% of the 13F portfolio, value $31,477,372.
13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 139,375 sharesChange vs previous 13F not available
1.33% of the 13F portfolio, value $38,335,069.
13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).